Will Slater & Gordon Limited win from the Volkswagen scandal

ASX investors would be forgiven to think that the VW scandal will have little impact on their portfolio. But that's not totally true as there is one that stands to benefit.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Volkswagen (VW) scandal might feel miles away from the ASX but there is at least one local stock that is likely to be impacted.

I am referring to law firm Slater & Gordon Limited (ASX: SGH) on the prospect of multiple class actions against the German automaker.

Slater & Gordon said its London business has received 500 calls so far from people who believe they have been misled by VW, according to the BBC.

There are around 11 million vehicles around the world that are affected by VW's "cheating software" that makes its diesel engines appear greener than they really are, and two million of these vehicles are in the UK while more than 50,000 of them are likely to be in Australia.

There's still a lot more water to run under this bridge before we can get a better sense of whether any lawsuits will be lodged in the UK or Australia, and whether Slater & Gordon will benefit from this.

While fellow law firm Shine Corporate Ltd (ASX:SHJ) could also benefit from any VW lawsuits, Slater & Gordon is best placed to capitalise on this opportunity due to its geographic reach and market leadership.

However, Slater & Gordon can do with any little piece of good news as it tries to shake-off its own problems surrounding its accounting practices, and its acquisition of UK firm Quindell's PSD.

Slater & Gordon went some way to address its accounting problems in recent days by making a number of adjustments to its accounts but looking at its share price, which is still trading under $3 when it was trading close to $8 in April, the news has not won over many sceptics.

The investigation by the Australian Securities & Investments Commission (ASIC) into the group's accounts is still ongoing, although the market is not expecting an adverse outcome given the changes the group has already made.

I think the stock is cheap under $3 but there are two key issues that will keep the stock under pressure. The first is the group's poor cash conversion with Slater & Gordon booking profits in excess of the cash they are collecting and you will probably have to wait to see its full year results next August to see any meaningful improvement on this front.

The other issue is the potential change in management. Short-sellers are probably targeting the stock on the belief (or hope) that the debacle will force some of its senior executives to resign.

Any change at the top typically puts the share price of a company under pressure and short-sellers betting on a fall in Slater & Gordon's share price will probably hold their bearish positions open until this issue is resolved.

On the upside, I think the stock has the potential to rally to over $5 once these issues are put to bed – but that could take 12 to 18 months to play out.

Motley Fool contributor Brendon Lau owns shares of Slater & Gordon Limited. Follow me on Twitter - https://twitter.com/brenlau Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »